Full Title
Intermediate-Size Patient Population Expanded Access to Bezuclastinib for Patients with NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis (EAP)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Brian Chernak’s office at 646-608-4366.
Protocol
25-364
Disease Status
Relapsed or Refractory
Investigator
Co-Investigators
Locations
ClinicalTrials.gov ID
NCT06915766
ClinicalTrials.gov